This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Walgreens Monthly Trend From June 2012 Through November 2012 Of Comparable Prescriptions Filled, Adjusted For Day Fall And Flu Impacts. (Graphic: Business Wire)

Total sales for the first quarter of fiscal 2013, which ended Nov. 30, were $17.34 billion, down 4.5 percent from $18.16 billion in the first quarter of fiscal 2012. Comparable store sales for the first quarter of fiscal 2013 decreased 7.7 percent, while front-end comparable store sales for the quarter decreased 2.0 percent. Prescriptions filled at comparable stores decreased 4.6 percent and total prescriptions decreased 3.0 percent in the first quarter. Comparable pharmacy sales for the first quarter decreased 10.8 percent.

Walgreens opened 39 stores during November, including 10 relocations and closed one.

At Nov. 30, Walgreens operated 8,516 locations in all 50 states, the District of Columbia, Puerto Rico and Guam. That includes 8,057 drugstores, 246 more than a year ago, including 107 net stores acquired over the last 12 months. The company also operates infusion and respiratory services facilities, specialty pharmacies and mail service facilities. Its Take Care Health Systems subsidiary manages more than 700 in-store convenient care clinics and worksite health and wellness centers.
   

November Comparable Sales and Prescriptions Filled
     

Cough,
 

Flu

Calendar

Generics

Cold, Flu

Shot

Actual

Shift Impact

Impact

Impact

Impact
 
Total Comp Sales -6.2% -0.2% -5.7% -0.1% 0.0%
 
Comp Front End -1.7% - - - -
 
Comp Rx Sales -8.8% -0.3% -9.0% -0.1% 0.0%
 
Comp Rx Scripts -2.9%* -0.3% - 0.2% 0.1%

* Includes +2.9 percentage points from patients filling more 90-day prescriptions

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,351.38 +293.03 1.82%
S&P 500 1,948.86 +35.01 1.83%
NASDAQ 4,749.9790 +113.8740 2.46%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs